News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
76,477 Results
Type
Article (3945)
Company Profile (10)
Press Release (72524)
Multimedia
Podcasts (11)
Webinars (2)
Section
Business (30392)
Career Advice (102)
Deals (4890)
Drug Delivery (22)
Drug Development (9315)
Employer Resources (17)
FDA (1832)
Job Trends (2612)
News (42131)
Policy (2873)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (221)
Accelerated approval (9)
ADA (6)
Adcomms (2)
Allergies (28)
Alliances (3177)
ALS (30)
Alzheimer's disease (218)
Antibody-drug conjugate (ADC) (94)
Approvals (1978)
Artificial intelligence (65)
ASCO (54)
Autoimmune disease (54)
Automation (10)
Bankruptcy (31)
Belgium (1)
Best Places to Work (2228)
BIO (4)
Biologics (1)
BIOSECURE Act (2)
Biosimilars (27)
BioSpace Insights (13)
Biotechnology (8)
Bladder cancer (57)
Brain cancer (9)
Breast cancer (166)
Cancer (1122)
Cardiovascular disease (103)
Career advice (97)
Career pathing (4)
CAR-T (42)
CDC (5)
CDMO (21)
Celiac Disease (1)
Cell therapy (111)
Cervical cancer (5)
Clinical research (9029)
Collaboration (213)
Commercialization (3)
Company closure (1)
Compensation (110)
Complete response letters (8)
COVID-19 (273)
CRISPR (14)
C-suite (106)
Cystic fibrosis (11)
Data (1648)
Denatured (1)
Depression (25)
Dermatology (23)
Diabetes (103)
Diagnostics (824)
Digital health (4)
Diversity, equity & inclusion (1)
Drug discovery (37)
Drug pricing (38)
Drug shortages (2)
Duchenne muscular dystrophy (44)
Earnings (23395)
Editorial (9)
Employer branding (4)
Employer resources (15)
Events (9288)
Executive appointments (114)
FDA (2584)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (213)
Gene editing (36)
Generative AI (7)
Gene therapy (91)
GLP-1 (189)
Government (503)
Guidances (242)
Healthcare (2395)
Hematology (36)
HIV (48)
Huntington's disease (8)
IgA nephropathy (32)
Immunology and inflammation (40)
Immuno-oncology (11)
Indications (51)
Infectious disease (333)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (19)
Intellectual property (24)
Interviews (14)
IPO (3072)
IRA (9)
Job creations (472)
Job search strategy (83)
JPM (8)
Kidney cancer (3)
Labor market (30)
Layoffs (117)
Leadership (2)
Legal (475)
Licensing (2)
Liver cancer (14)
Longevity (4)
Lung cancer (184)
Lymphoma (95)
Machine learning (5)
Management (6)
Manufacturing (126)
Marketing (3)
MASH (52)
Medical affairs (1)
Medical device (1843)
Medtech (1872)
Mergers & acquisitions (1995)
Metabolic disorders (287)
mRNA (26)
Multiple sclerosis (23)
NASH (4)
Neurodegenerative disease (49)
Neuropsychiatric disorders (22)
Neuroscience (426)
NextGen: Class of 2026 (697)
Non-profit (436)
Now hiring (5)
Obesity (124)
Opinion (31)
Ovarian cancer (41)
Pain (28)
Pancreatic cancer (48)
Parkinson's disease (30)
Partnered (4)
Patents (42)
Patient recruitment (79)
Peanut (9)
People (3437)
Peptides (1)
Pharmaceutical (1)
Pharmacy benefit managers (8)
Phase 1 (1980)
Phase 2 (3730)
Phase 3 (4049)
Pipeline (2811)
Policy (53)
Postmarket research (340)
Preclinical (595)
Press Release (7)
Prostate cancer (66)
Psychedelics (11)
Radiopharmaceuticals (48)
Rare diseases (175)
Real estate (557)
Recruiting (8)
Regulatory (2688)
Reports (17)
Research institute (225)
Resumes & cover letters (11)
Rett syndrome (6)
RNA editing (2)
RSV (21)
Schizophrenia (44)
Series A (32)
Series B (18)
Service/supplier (1)
Sickle cell disease (24)
Special edition (9)
Spinal muscular atrophy (36)
Sponsored (6)
Startups (311)
Stomach cancer (4)
Supply chain (13)
Tariffs (17)
The Weekly (10)
Vaccines (150)
Venture capital (14)
Weight loss (81)
Women's health (19)
Worklife (4)
Date
Today (10)
Last 7 days (86)
Last 30 days (313)
Last 365 days (4853)
2026 (3401)
2025 (4829)
2024 (4975)
2023 (5683)
2022 (6295)
2021 (6530)
2020 (6100)
2019 (5496)
2018 (4129)
2017 (3457)
2016 (2796)
2015 (3778)
2014 (2381)
2013 (1654)
2012 (1722)
2011 (2189)
2010 (1956)
Location
Africa (77)
Alabama (6)
Arizona (39)
Asia (4531)
Australia (621)
California (2355)
Canada (550)
China (223)
Colorado (101)
Connecticut (134)
Delaware (125)
Europe (11404)
Florida (288)
Georgia (84)
Hawaii (1)
Idaho (11)
Illinois (196)
India (11)
Indiana (123)
Iowa (3)
Japan (132)
Kansas (12)
Kentucky (12)
Louisiana (19)
Maine (17)
Maryland (267)
Massachusetts (1549)
Michigan (39)
Minnesota (115)
Mississippi (1)
Missouri (22)
Montana (3)
Nebraska (1)
Nevada (12)
New Hampshire (12)
New Jersey (879)
New York (699)
North Carolina (262)
North Dakota (1)
Northern California (1290)
Ohio (54)
Oklahoma (2)
Oregon (1)
Pennsylvania (490)
Puerto Rico (1)
Rhode Island (3)
South America (113)
South Carolina (5)
Southern California (896)
Tennessee (31)
Texas (295)
United States (8257)
Utah (74)
Virginia (35)
Washington D.C. (10)
Washington State (161)
Wisconsin (15)
Wyoming (2)
76,477 Results for "35".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IPSEN - Buy-back programme - Art 5 of MAR - Week 35 - 2026
August 31, 2026
·
1 min read
Press Releases
Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
August 31, 2026
·
3 min read
Press Releases
Tenon Medical, Inc. Announces 1:35 Reverse Stock Split
August 6, 2026
·
5 min read
Press Releases
Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
September 2, 2026
·
3 min read
Press Releases
EIT Pharma Closes Oversubscribed $35 Million Series A Round, Led by Propel Bio Partners
August 31, 2026
·
3 min read
Press Releases
Rapid Medical Announces FDA Clearance of DRIVEWIRE™ 35 and First Stroke Cases
July 22, 2026
·
2 min read
Press Releases
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
March 31, 2026
·
1 min read
Press Releases
Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: ASC36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and ASC36_35FDC Once-Monthly Injection, a Co-Formulation of ASC36 and GLP-1R/GIPR Peptide Agonist ASC35
August 10, 2026
·
6 min read
Press Releases
Carestream Launches NEW Lux HD 35 and Lux HD 43 Detectors for Medical Imaging
June 10, 2026
·
2 min read
Press Releases
Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology
May 22, 2026
·
5 min read
1 of 7,648
Next
